WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹19 Cr | ₹-52 Cr | ₹-198 Cr | ₹-189 Cr | ₹-258 Cr |
What is the latest Net Current Assets ratio of WANBURY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹-52 Cr |
| Mar2023 | ₹-198 Cr |
| Mar2022 | ₹-189 Cr |
| Mar2021 | ₹-258 Cr |
How is Net Current Assets of WANBURY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | Positive | |
| Mar2024 | ₹-52 Cr | Negative | |
| Mar2023 | ₹-198 Cr | Negative | |
| Mar2022 | ₹-189 Cr | Negative | |
| Mar2021 | ₹-258 Cr | - | |
Compare Net Current Assets of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹874.6 Cr | 19.8% | 6.5% | -0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 19.8% |
6.5% |
-0.1% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses